Tandem Control IQ Pump

Trying to keep your blood sugar in range can be stressful and time-consuming. Our Control-IQ advanced hybrid closed-loop technology makes it easier by predicting and helping to prevent highs and lows.

AUTOMATIC INSULIN ADJUSTMENTS

Control-IQ™ technology automatically adjusts insulin levels based on Dexcom G6 continuous glucose monitoring (CGM) readings.*

CORRECTION BOLUSES

Control-IQ technology can also deliver automatic correction boluses (up to one an hour) to help prevent hyperglycemia.^†

ACTIVITY SETTINGS

Control-IQ technology includes optional settings for Sleep and Exercise that adjust range of treatment values for more control.

More time in range

Average additional time in range per day for clinical study participants who used Control-IQ technology on the t:slim X2™ insulin pump.¹

Said it’s easy to use

Percent of clinical study participants who used Control-IQ technology on the t:slim X2 insulin pump and said it was easy to use.²

How it works

The t:slim X2 insulin pump with Control‑IQ technology is designed to help increase time in range (70-180 mg/dL)^‡ using Dexcom G6 CGM values to predict glucose levels 30 minutes ahead and adjust insulin delivery accordingly.

CONTROL-IQ STATUS ICONS

Icons display on the pump screen to visually indicate when insulin delivery is increasing, decreasing, or stopped. Please refer to the table for a breakdown of status icons

Easy to use. Easy to love.

We understand that you want your kid to enjoy all the wonderful parts of growing up, instead of being burdened by constantly worrying about their diabetes. The t:slim X2 insulin pump with Control-IQ technology operates in the background without needing constant input or interaction, so your kid can be a kid.

Connect at a glance

The t:connect® mobile app serves as a discreet secondary display for your t:slim X2 insulin pump, so you can stay informed of your diabetes management from the convenience of your phone. View your pump data, including basal and bolus insulin events, insulin on board, carbs, settings, and both pump and sensor status.^§

Zero Fingersticks

Dexcom G6 CGM integration with the t:slim X2 pump provides exceptional accuracy³ for optimized insulin delivery. Dexcom G6 is the first real-time, integrated continuous glucose monitoring (iCGM) system requiring zero fingersticks for calibration or mealtime dosing.^{^}

^ If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

So what's next?

Whether you’re ready to get the t:slim X2 insulin pump or just looking to check your insurance coverage, everything you need is right here.

Responsible Use of Control‑IQ Technology

Even with advanced systems such as the t:slim X2 insulin pump with Control-IQ technology, you are still responsible for actively managing your diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires your accurate input of information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless you use all system components, including your CGM, infusion sets and pump cartridges, as instructed. Importantly, the system cannot adjust your insulin dosing if the pump is not receiving CGM readings. Since there are situations and emergencies that the system may not be capable of identifying or addressing, always pay attention to your symptoms and treat according to your healthcare provider’s recommendations.

Ready to Order?

Click Here

* Dexcom CGM sold separately. Transmitter can only be paired with one medical device (either a Dexcom receiver or t:slim X2 insulin pump) and one consumer device (phone or tablet) at the same time.
† If glucose values are predicted to be above 180 mg/dL, Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL and delivers 60% of that value. An Automatic Correction Bolus will not occur within 60 minutes of a bolus that has been delivered or cancelled.
‡ As measured by CGM.
§ The information on the t:connect mobile app display may not be identical to the current status of your pump. Wireless uploads from the t:connect mobile app to the cloud-based t:connect web application require a compatible phone and an internet or wireless data connection. Uploads to the t:connect web application do not take place in real time and should not be relied upon by healthcare providers or caregivers for remote patient monitoring. Standard carrier data rates may apply.
^ If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

References

1. Brown SA, Kovatchev BP, Raghinaru D, et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Eng J Med. 2019;381(18):1701-1717.
2. Brown, S. Clinical acceptance of the artificial pancreas: Glycemia outcomes from a 6-month multicenter RCT. 2019 ADA 79th Scientific Sessions, San Francisco, CA.
3. Dexcom G6 CGM System User Guide, 2018.

Important Safety Information

RX ONLY. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump and Control-IQ technology are indicated for use with NovoLog or Humalog U-100 insulin.

t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The t:slim X2 pump is indicated for use in individuals six years of age and greater. Control-IQ technology: Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater.

WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump and Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit www.tandemdiabetes.com/safetyinfo for additional important safety information.

t:connect mobile app: The t:connect mobile app is intended to be a secondary display for compatible Tandem Diabetes Care insulin pumps and is capable of wirelessly uploading pump data it receives into the t:connect web application. The t:connect mobile app is not intended to control an insulin pump and is not intended to be a replacement for the information displayed on your insulin pump. Dosing decisions should not be made based on the secondary display device. The user should follow instructions on the continuous glucose monitoring system and insulin pump. This secondary display device is not intended to replace self-monitoring practices as advised by a physician.